Eddy W. Yue

2.9k total citations
27 papers, 1.3k citations indexed

About

Eddy W. Yue is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Eddy W. Yue has authored 27 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 8 papers in Organic Chemistry and 8 papers in Oncology. Recurrent topics in Eddy W. Yue's work include Plant biochemistry and biosynthesis (7 papers), Natural product bioactivities and synthesis (6 papers) and Protein Tyrosine Phosphatases (5 papers). Eddy W. Yue is often cited by papers focused on Plant biochemistry and biosynthesis (7 papers), Natural product bioactivities and synthesis (6 papers) and Protein Tyrosine Phosphatases (5 papers). Eddy W. Yue collaborates with scholars based in United States. Eddy W. Yue's co-authors include K. C. Nicolaou, Adrian L. Smith, Alan Nadin, K. C. Nicolaou, James E. Leresche, Andrew P. Combs, Timothy C. Burn, Holly K. Koblish, Peggy Scherle and Zhen Yang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Journal of Biological Chemistry.

In The Last Decade

Eddy W. Yue

27 papers receiving 1.3k citations

Peers

Countries citing papers authored by Eddy W. Yue

Since Specialization

Citations

This map shows the geographic impact of Eddy W. Yue's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eddy W. Yue with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eddy W. Yue more than expected).

Fields of papers citing papers by Eddy W. Yue

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eddy W. Yue. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eddy W. Yue. The network helps show where Eddy W. Yue may publish in the future.

Co-authorship network of co-authors of Eddy W. Yue

This figure shows the co-authorship network connecting the top 25 collaborators of Eddy W. Yue. A scholar is included among the top collaborators of Eddy W. Yue based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eddy W. Yue. Eddy W. Yue is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	OP0275 THE PI3KΔ INHIBITOR INCB050465 AMELIORATES SALIVARY GLAND PATHOLOGY AND REDUCES AUTOANTIBODY FORMATION IN A MURINE MODEL OF SJÖGREN'S SYNDROME 2019 ·Annals of the Rheumatic Diseases ·(unknown), (unknown), Niu Shin, (unknown), Eddy W. Yue, Andrew P. Combs, Julian Oliver, (unknown), (unknown), Eduardo Huarte, Paul A. Smith	2
2	Abstract 143: Preclinical studies on potential therapeutic combination partners for the potent and selective PI3Kδ inhibitor INCB050465 in DLBCL 2017 ·Cancer Research ·Matthew C. Stubbs, Robert J. Collins, Leslie Hall, Alla Volgina, Holly K. Koblish, Sang Hyun Lee, Timothy C. Burn, (unknown), Lü Jin, Eddy W. Yue, Yunlong Li, Andrew P. Combs, Wenqing Yao, Gregory Hollis, Reid Huber, Bruce Ruggeri, Peggy Scherle	1
3	Abstract 4904: The BET inhibitor INCB054329 enhances the activity of checkpoint modulation in syngeneic tumor models 2016 ·Cancer Research ·Holly K. Koblish, Michael Hansbury, Leslie Hall, Liang-Chuan Wang, Yue Zhang, Maryanne Covington, Timothy C. Burn, Mark Rupar, Christine Gardiner, Thomas Condamine, (unknown), Matthew C. Stubbs, Eddy W. Yue, Richard Sparks, Thomas Maduskuie, Andrew P. Combs, Gregory Hollis, Reid Huber, (unknown), Peggy Scherle	4
4	Abstract C103: The combination of PI3kδ-selective inhibition and immunomodulation shows efficacy in solid tumor models 2015 ·Molecular Cancer Therapeutics ·Holly K. Koblish, Liang-Chuan Wang, Michael Hansbury, Yue Zhang, Gengjie Yang, Timothy C. Burn, Paul Waeltz, Mark Rupar, Eddy W. Yue, Brent Douty, Thomas Maduskuie, Nikoo Falahatpisheh, Yunlong Li, Andrew P. Combs, Gregory Hollis, Reid Huber, Peggy Scherle	5
5	Discovery of matrix metalloproteases selective and activated peptide–doxorubicin prodrugs as anti-tumor agents 2010 ·Bioorganic & Medicinal Chemistry Letters ·Zilun Hu, (unknown), Charles F. Albright, Nilsa Graciani, Eddy W. Yue, Mingzhu Zhang, Shuyun Zhang, R. Brückner, Melody Diamond, Randine L. Dowling, Maria Rafalski, Swamy Yeleswaram, George L. Trainor, Steven P. Seitz, Wei Han	12
6	Discovery of Potent Competitive Inhibitors of Indoleamine 2,3-Dioxygenase with in Vivo Pharmacodynamic Activity and Efficacy in a Mouse Melanoma Model 2009 ·Journal of Medicinal Chemistry ·Eddy W. Yue, Brent Douty, Brian Wayland, Michael J. Bower, Xiangdong Liu, Lynn Leffet, Qian Wang, Kevin Bowman, Michael Hansbury, Changnian Liu, Min Wei, Yanlong Li, Richard Wynn, Timothy C. Burn, Holly K. Koblish, Jordan S. Fridman, Brian Metcalf, Peggy Scherle, Andrew P. Combs	187
7	Isothiazolidinone inhibitors of PTP1B containing imidazoles and imidazolines 2007 ·Bioorganic & Medicinal Chemistry Letters ·Brent Douty, Brian Wayland, J. Paul, Michael J. Bower, James R. Pruitt, Lori L. Bostrom, Min Wei, Ronald M. Klabe, Lucie Gonneville, Richard Wynn, Timothy C. Burn, Phillip C.C. Liu, Andrew P. Combs, Eddy W. Yue	55
8	Structural Insights into the Design of Nonpeptidic Isothiazolidinone-containing Inhibitors of Protein-tyrosine Phosphatase 1B 2006 ·Journal of Biological Chemistry ·J. Paul, Lucie Gonneville, Milton C. Hillman, (unknown), Eddy W. Yue, Brent Douty, Brian Wayland, Padmaja Polam, Matthew L. Crawley, Erin McLaughlin, Richard Sparks, Brian Glass, Amy Takvorian, Andrew P. Combs, Timothy C. Burn, Gregory Hollis, Richard Wynn	55
9	Structural Basis for Inhibition of Protein-tyrosine Phosphatase 1B by Isothiazolidinone Heterocyclic Phosphonate Mimetics 2006 ·Journal of Biological Chemistry ·J. Paul, Lucie Gonneville, Milton C. Hillman, (unknown), Min Wei, Brian G. Reid, Ronald M. Klabe, Eddy W. Yue, Brian Wayland, Brent Douty, Padmaja Polam, Zelda R. Wasserman, Michael J. Bower, Andrew P. Combs, Timothy C. Burn, Gregory Hollis, Richard Wynn	61
10	Isothiazolidinone heterocycles as inhibitors of protein tyrosine phosphatases: Synthesis and structure–activity relationships of a peptide scaffold 2006 ·Bioorganic & Medicinal Chemistry ·Eddy W. Yue, Brian Wayland, Brent Douty, Matthew L. Crawley, Erin McLaughlin, Amy Takvorian, Zelda R. Wasserman, Michael J. Bower, Min Wei, Yanlong Li, J. Paul, Lucie Gonneville, Richard Wynn, Timothy C. Burn, Phillip C.C. Liu, Andrew P. Combs	44
11	Inhibitors of Cyclin-dependent Kinases as Anti-tumor Agents 2006 ·Paul Smith, Eddy W. Yue	42
12	Synthesis and evaluation of indenopyrazoles as cyclin-dependent kinase inhibitors. Part 4: Heterocycles at C3 2003 ·Bioorganic & Medicinal Chemistry Letters ·Eddy W. Yue, (unknown), C. Anne Higley, Jay A. Markwalder, Catherine R. Burton, Pamela A. Benfield, Robert H. Grafström, Sarah Cox, J.K. Muckelbauer, Angela Smallwood, Haiying Chen, C.-H. Chang, George L. Trainor, Steven P. Seitz	30
13	Synthesis and Evaluation of Indenopyrazoles as Cyclin-Dependent Kinase Inhibitors. 3. Structure Activity Relationships at C3 2002 ·Journal of Medicinal Chemistry ·Eddy W. Yue, C. Anne Higley, (unknown), David J. Carini, David A. Nugiel, (unknown), Pamela A. Benfield, Catherine R. Burton, Sarah Cox, Robert H. Grafström, (unknown), (unknown), John F. Boylan, J.K. Muckelbauer, Angela Smallwood, Haiying Chen, Chong‐Hwan Chang, Steven P. Seitz, George L. Trainor	40
14	Total synthesis of selected natural products 1997 ·Pure and Applied Chemistry ·K. C. Nicolaou, Eddy W. Yue	6
15	An Olefin Metathesis Based Strategy for the Construction of the JKL, OPQ, and UVW Ring Systems of Maitotoxin 1996 ·Journal of the American Chemical Society ·K. C. Nicolaou, Maarten H. D. Postema, Eddy W. Yue, Alan Nadin	80
16	Synthesis of Zaragozic Acid A/Squalestatin S1 1995 ·Chemistry - A European Journal ·K. C. Nicolaou, Eddy W. Yue, (unknown), Alan Nadin, Zhen Yang, James E. Leresche, Tatsuo Tsuri, (unknown), Francesco De Riccardis	82
17	Total Synthesis of Zaragozic Acid A/Squalestatin S1 1994 ·Angewandte Chemie International Edition in English ·K. C. Nicolaou, Alan Nadin, James E. Leresche, Eddy W. Yue, (unknown)	57
18	Synthesis of the First Fully Functionalized Core of the Zaragozic Acids/Squalestatins 1994 ·Angewandte Chemie International Edition in English ·K. C. Nicolaou, Alan Nadin, James E. Leresche, (unknown), Tatsuo Tsuri, Eddy W. Yue, Zhen Yang	39
19	Saragossasäure A/Squalestatin S1: synthetische und retrosynthetische Untersuchungen 1994 ·Angewandte Chemie ·K. C. Nicolaou, Eddy W. Yue, (unknown), Francesco De Riccardis, Alan Nadin, James E. Leresche, (unknown), Zhen Yang	21
20	Chemistry and biology of natural and designed enediynes. 1993 ·Proceedings of the National Academy of Sciences ·K. C. Nicolaou, Adrian L. Smith, Eddy W. Yue	202

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact